IRDAI orders Care Well being Insurance coverage to revoke Rashmi Saluja’s Inventory Choices

The Insurance coverage Regulatory and Improvement Authority of India (IRDAI) has directed Care Well being Insurance coverage Ltd. (previously referred to as Religare Well being Insurance coverage) to purchase again 7.57 million shares allotted to Rashmi Saluja, the non-executive director and chairperson of Religare Enterprises, and levied a penalty of Rs 1 crore for failing to acquire prior approval for such remuneration.

IRDAI emphasised that Saluja’s twin function as government chairperson of Religare Enterprises doesn’t exempt her from regulatory compliance. The issuance of inventory choices to her breached the IRDA Act of 1999 and associated pointers, the regulator acknowledged.

Care Well being Insurance coverage should repurchase the 7.57 million shares allotted to Saluja at Rs. 45.32 every and cancel any unexercised or unvested choices instantly, the order mentioned. Future grants of inventory choices to her are prohibited. The corporate is required to verify compliance inside 15 days and pay a Rs. 1 crore penalty inside 45 days, charging it to shareholders’ accounts.

In 2019, IRDAI permitted Saluja’s appointment for her widespread director function in Care Well being and Religare Finvest Restricted, and in 2022, her function in Care Well being and Religare Insurance coverage Broking. Nonetheless, in 2021, the insurer’s request to grant inventory choices to Saluja was rejected by the regulator. Regardless of this, Care Well being issued 22.7 million ESOPs, of which Saluja exercised 7.57 million by October 2023. In Could this 12 months, the regulator issued a show-cause discover on this matter.

Care Well being responded by stating that Saluja was granted ESOPs in her capability as government chairperson of Religare Enterprises Restricted and never as non-executive director of Care Well being. IRDAI didn’t settle for this clarification, deeming it a defiance of the rules.This regulatory motion follows a show-cause discover issued amid a dispute over Religare Enterprises’ management between its board, subsidiary Care Well being Insurance coverage, and the promoter Dabur household. The Burman household, the biggest shareholder of Religare Enterprises, claims that 22.7 million choices have been illegally issued to Saluja, demanding their cancellation. Regardless of IRDAI’s prior refusal, Care Well being allotted inventory choices value roughly Rs. 250 crore to Saluja, representing 2.5% of its shareholding, ET reported on July 12. A Proper to Data question revealed that Care Well being sought approval for the ESOPs in December 2021, which was not granted.In a associated improvement, the Securities Appellate Tribunal has instructed Religare Enterprises to use for an open supply by July 22, in compliance with a SEBI order dated June 19, 2024, because the battle for management of Religare Enterprises intensifies.